Right of use assets

12 Months Ended

Jun. 30, 2025

Right Of Use Assets

Right of use assets

9. Right of use assets

	2025			2025			2024
	US$			S$			S$
Cost
At beginning of financial year		2,164,551			2,753,093			2,753,093
Additions		2,575,627			3,275,940			-
Acquisition		3,793,697			4,825,203			-
Written off		(3,118,402	)		(3,966,296	)		-
At end of financial year		5,415,473			6,887,940			2,753,093
Accumulated Depreciation
At beginning of financial year		2,146,106			2,729,633			2,230,998
Acquisition		2,902,285			3,691,417			-
Depreciation		843,989			1,073,469			498,635
Written off		(2,974,369	)		(3,783,101	)		-
At end of financial year		2,918,011			3,711,418			2,729,633
Carrying amount		2,497,462			3,176,522			23,460

Basel Medical Group Ltd. and its Subsidiaries

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For year ended June 30, 2025 and 2024